BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• 

  Immunology and inflammation

  Sanofi, Regeneron Tout Dupixent’s Effectiveness in Patients With Darker Skin Tone

  Atopic dermatitis manifests differently in patients with darker skin color, according to the companies, including subtler presentations and more severe and prolonged lesions compared to patients with lighter skin.

  June 9, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Weight loss

  Metsera Shares Rise as Monthly Weight Loss Injection Shaves Over 8% Body Weight at 36 Days

  In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin injection MET-233i showed promising weight-loss after a little more than a month of treatment.

  June 9, 2025

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Neurodegenerative disease

  Avidity’s siRNA Muscular Dystrophy Drug Improves Mobility, Boosts Muscle Strength

  Avidity has been given the go-ahead by the FDA to request accelerated approval of delpacibart braxlosiran—potentially the first disease-modifying treatment for facioscapulohumeral muscular dystrophy—with an application in the second half of 2026.

  June 9, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• 

  Rare diseases

  Apellis, Sobi See Potential ‘Best-in-Class’ Efficacy for Empaveli in Rare Kidney Diseases

  Empaveli reduced proteinuria by 68% versus placebo in glomerulopathy and glomerulonephritis, an effect that was sustained through one year of follow-up.

  June 9, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Vaccines

  ACIP Members Receive Termination Notices as Fears Mount Over RFK Jr.’s Vaccine Machinations

  The loss of special government employee status for four members of the CDC’s Advisory Committee on Immunization Practices follows the resignation of ACIP co-lead Lakshmi Panagiotakopoulos, who left in protest of a controversial change in COVID-19 recommendations for healthy children and pregnant women.

  June 9, 2025

   · 

  2 min read

   · 

  Heather McKenzie
• 

  vaccines

  In ‘Bold’ Move, RFK Jr. ‘Retires’ All 17 Members of CDC’s Vaccine Committee

  Two weeks of upheaval at the CDC culminated Monday in the complete reconstitution of the CDC’s Advisory Committee on Immunization Practices as HHS Secretary Robert F. Kennedy Jr. pens op-ed criticizing “conflicts of interest” he says exist on the current committee.

  June 9, 2025

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Duchenne muscular dystrophy

  Keros To Return $375M to Investors After Shareholder Activism, Safety Signal

  After a major shareholder pushed back, Keros is returning half of its capital to investors in a move that Guggenheim analysts called “a positive step forward.”

  June 9, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• 

  Drug development

  siRNA on the Precipice as Candidates Reach Beyond the Liver

  As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set a goal of targeting small interfering RNA to any tissue by 2030.

  June 9, 2025

   · 

  7 min read

   · 

  Shawna Williams
• 

  Cardiovascular disease

  Merck Moves Forward in Bid To Bring First Oral PCSK9 Inhibitor to Market

  Merck’s enlicitide decanoate significantly lowered low-density lipoprotein cholesterol in two Phase III trials, unlocking what BMO Capital Markets called a “multi-billion dollar opportunity” for the pharma.

  June 9, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

  June 9, 2025

   · 

  1 min read